We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter describes families of relationship- and emotion-focused therapies, whose members include psychoanalytic, psychodynamic and humanistic treatments. It begins with Freud’s traditional psychoanalysis, which stresses the need for clients to develop insight into their primitive drives, unconscious conflicts, and patterns of relating. It next covers other psychodynamic approaches that share ideas with traditional psychoanalysis, including interpersonal therapy. It also describes humanistic treatments, including person-centered, Gestalt, and existential therapies, all of which emphasize each client’s unique way of experiencing the world. Psychodynamic and humanistic treatments are considered relational approaches because they place strong emphasis on the role of the therapeutic relationship in treatment. The chapter also describes other treatments such as motivational interviewing and emotion-focused therapy that emphasize the role of emotion and interpersonal relationships in helping clients overcome psychological problems.
Problematic drinking frequently co-occurs with depression among young adults, but often remains unaddressed in depression treatment. Evidence is insufficient on whether digital alcohol interventions can be effective in this young comorbid population. In a randomized controlled trial, we examined the effectiveness of Beating the Booze (BtB), an add-on digital alcohol intervention to complement depression treatment for young adults.
Methods
Participants were randomized to BtB + depression treatment as usual (BTB + TAU, n = 81) or TAU (n = 82). The primary outcome was treatment response, a combined measure for alcohol and depression after 6-month follow-up. Secondary outcomes were number of weekly drinks (Timeline Follow-back) and depressive symptoms (Center for Epidemiologic Studies Depression scale). Treatment response was analyzed using generalized linear modeling and secondary outcomes using robust linear mixed modeling.
Results
Low treatment response was found due to lower than expected depression remission rates. No statistically significant between-group effect was found for treatment response after 6-month follow-up (odds ratio 2.86, p = 0.089, 95% confidence interval [CI] 0.85–9.63). For our secondary outcomes, statistically significant larger reductions in weekly drinks were found in the intervention group after 3-month (B = −4.00, p = 0.009, 95% CI −6.97 to −1.02, d = 0.27) and 6-month follow-up (B = −3.20, p = 0.032, 95% CI −6.13 to −0.27, d = 0.23). We found no statistically significant between-group differences on depressive symptoms after 3-month (B = −0.57, p = 0.732, 95% CI −3.83 to 2.69) nor after 6-month follow-up (B = −0.44, p = 0.793, 95% CI −3.69 to 2.82).
Conclusions
The add-on digital alcohol intervention was effective in reducing alcohol use, but not in reducing depressive symptoms and treatment response among young adults with co-occurring depressive disorders and problematic alcohol use.
Trial registration:
Pre-registered on October 29, 2019 in the Overview of Medical Research in the Netherlands (OMON), formerly the Dutch Trial Register(https://onderzoekmetmensen.nl/en/trial/49219).
Addressing aggressive behavior in adolescence is a key step toward preventing violence and associated social and economic costs in adulthood. This study examined the secondary effects of the personality-targeted substance use preventive program Preventure on aggressive behavior from ages 13 to 20.
Methods
In total, 339 young people from nine independent schools (M age = 13.03 years, s.d. = 0.47, range = 12–15) who rated highly on one of the four personality traits associated with increased substance use and other emotional/behavioral symptoms (i.e. impulsivity, anxiety sensitivity, sensation seeking, and negative thinking) were included in the analyses (n = 145 in Preventure, n = 194 in control). Self-report assessments were administered at baseline and follow-up (6 months, 1, 2, 3, 5.5, and 7 years). Overall aggression and subtypes of aggressive behaviors (proactive, reactive) were examined using multilevel mixed-effects analysis accounting for school-level clustering.
Results
Across the 7-year follow-up period, the average yearly reduction in the frequency of aggressive behaviors (b = −0.42; 95% confidence interval [CI] −0.64 to −0.20; p < 0.001), reactive aggression (b = −0.22; 95% CI 0.35 to −0.10; p = 0.001), and proactive aggression (b = −0.14; 95% CI −0.23 to −0.05; p = 0.002) was greater for the Preventure group compared to the control group.
Conclusions
The study suggests a brief personality-targeted intervention may have long-term impacts on aggression among young people; however, this interpretation is limited by imbalance of sex ratios between study groups.
Substance use disorders (SUDs) are frequently encountered in hospice palliative care (HPC) and pose substantial quality-of-life issues for patients. However, most HPC physicians do not directly treat their patients’ SUDs due to several institutional and personal barriers. This review will expand upon arguments for the integration of SUD treatment into HPC, will elucidate challenges for HPC providers, and will provide recommendations that address these challenges.
Methods
A thorough review of the literature was conducted. Arguments for the treatment of SUDs and recommendations for physicians have been synthesized and expanded upon.
Results
Treating SUD in HPC has the potential to improve adherence to care, access to social support, and outcomes for pain, mental health, and physical health. Barriers to SUD treatment in HPC include difficulties with accurate assessment, insufficient training, attitudes and stigma, and compromised pain management regimens. Recommendations for physicians and training environments to address these challenges include developing familiarity with standardized SUD assessment tools and pain management practice guidelines, creating and disseminating visual campaigns to combat stigma, including SUD assessment and intervention as fellowship competencies, and obtaining additional training in psychosocial interventions.
Significance of results
By following these recommendations, HPC physicians can improve their competence and confidence in working with individuals with SUDs, which will help meet the pressing needs of this population.
Screen use at mealtimes is associated with poor dietary and psychosocial outcomes in children and is disproportionately prevalent among families of low socio-economic position (SEP). This study aimed to explore experiences of reducing mealtime screen use in mothers of low SEP with young children.
Design:
Motivational interviews, conducted via Zoom or telephone, addressed barriers and facilitators to reducing mealtime screen use. Following motivational interviews, participants co-designed mealtime screen use reduction strategies and trialled these for 3–4 weeks. Follow-up semi-structured interviews then explored maternal experiences of implementing strategies, including successes and difficulties. Transcripts were analysed thematically.
Setting:
Australia.
Participants:
Fourteen mothers who had no university education and a child between six months and six years old.
Results:
A range of strategies aimed to reduce mealtime screen use were co-designed. The most widely used strategies included changing mealtime location and parental modelling of expected behaviours. Experiences were influenced by mothers’ levels of parenting self-efficacy and mealtime consistency, included changes to mealtime foods and an increased value of mealtimes. Experiences were reportedly easier, more beneficial and offered more opportunities for family communication, than anticipated. Change required considerable effort. However, effort decreased with consistency.
Conclusions:
The diverse strategies co-designed by mothers highlight the importance of understanding why families engage in mealtime screen use and providing tailored advice for reduction. Although promising themes were identified, in this motivated sample, changing established mealtime screen use habits still required substantial effort. Embedding screen-free mealtime messaging into nutrition promotion from the inception of eating will be important.
This review traces the development of motivational interviewing (MI) from its happenstance beginnings and the first description published in this journal in 1983, to its continuing evolution as a method that is now in widespread practice in many professions, nations and languages. The efficacy of MI has been documented in hundreds of controlled clinical trials, and extensive process research sheds light on why and how it works. Developing proficiency in MI is facilitated by feedback and coaching based on observed practice after initial training. The author reflects on parallels between MI core processes and the characteristics found in 70 years of psychotherapy research to distinguish more effective therapists. This suggests that MI offers an evidence-based therapeutic style for delivering other treatments more effectively. The most common use of MI now is indeed in combination with other treatment methods such as cognitive behaviour therapies.
This chapter describes pseudoscience and questionable ideas related to substance use disorders and addiction. The chapter opens by discussing diagnostic controversies and myths that influence treatments. Dubious treatments include naturopathy, homeopathy, orthomolecular medicine, acupuncture, energy medicine, hypnosis, chiropractic care, and animal-assisted therapy. The fuzzy boundary between science-based and pseudoscientific approaches is also considered. The chapter closes by reviewing research-supported approaches.
The chapter describes how to manage ruptures in the therapeutic alliance. It opens by outlining a conceptual model to understand the ruptures and proceeds to consider the ways that ruptures may manifest at different points in psychotherapy. One way to respond to some ruptures in alliance in via enhancing motivation and therefore the technique of Motivational Interviewing is described in detail; outlining the steps of expressing empathy, developing discrepancies (between actual and desired outcomes), avoiding argumentation, rolling with resistance and supporting self-efficacy. The chapter reviews ways to manage the assignment and review of homework exercises so that they are a productive element in clinical psychology practice. The chapter concludes with a close examination of psychotherapeutic process; defining what “process” is, and how to work with transference and countertransference.
The chapter outlines for the clinical psychologist how longer treatments can be adapted in the form of brief interventions. As an example with a strong evidence base, we focus on brief interventions for alcohol use. The aim of these interventions is to raise awareness of alcohol-related risk and reduce hazardous and harmful drinking behaviour. The chapter outlines a detailed, practical example of a brief intervention for problem drinking.
This chapter introduces the intersections between mental health care and drug and alcohol care. It addresses the implications for holistic health care needs related to dual drug and alcohol use, and concurrent mental health conditions. It tells the contemporary, real-life story of a person who developed an episode of psychosis following consumption of premixed alcohol and caffeine drinks. The chapter also describes change models applied to substance use and recovery, such as motivational interviewing and stages of change readiness. Both common and less common drugs and their misuse affect the physical, social, cognitive and mental health dimensions of people with mental health conditions. Reflective exercises guide readers to consider how they will be able to promote mental health and well-being and minimise drug-related harm to individuals and communities in a practice context.
This chapter introduces the intersections between mental health care and drug and alcohol care. It addresses the implications for holistic health care needs related to dual drug and alcohol use, and concurrent mental health conditions. It tells the contemporary, real-life story of a person who developed an episode of psychosis following consumption of premixed alcohol and caffeine drinks. The chapter also describes change models applied to substance use and recovery, such as motivational interviewing and stages of change readiness. Both common and less common drugs and their misuse affect the physical, social, cognitive and mental health dimensions of people with mental health conditions. Reflective exercises guide readers to consider how they will be able to promote mental health and well-being and minimise drug-related harm to individuals and communities in a practice context.
This chapter explores the biopsychosocial factors that influence prescribing behaviour. It begins by introducing theories of behaviour to explore how health systems, pharmaceutical companies, individual professions, roles and identities, colleagues, patients, the time of day, personal beliefs, habits, emotions and the environmental setting can all influence prescribers and their prescribing behaviour. It also discusses the influences of wider society and culture and how that has also shaped healthcare, prescribing practice and patients’ understandings of illness and their expectations around healthcare and treatment. Having taken a look at all these influences on prescribing behaviour, it gives an overview of interventions that help prescribers optimise their prescribing decision making and prescribing behaviours as well as optimise patient satisfaction with and adherence to treatment. These include person-centred and shared decision making, using motivational interviewing to enhance communication during consultations and evidence-based training programmes that have used these approaches to optimise non-medical prescribing.
A substantial proportion of patients receiving cognitive behavioural therapy (CBT) do not achieve remission, and drop-out is considerable. Motivational interviewing (MI) may influence non-response and drop-out. Previous research shows that MI as a pre-treatment to CBT produces moderate effects compared with CBT alone. Studies integrating MI with CBT (MI-CBT) are scarce.
Aims:
To test the feasibility of MI-CBT in terms of therapist competence in MI and various participant measures, including recruitment and retention. In addition, separate preliminary evaluations were conducted, exploring the effects of CBT alone for anxiety disorders and depression, and of MI-CBT for anxiety disorders, depression and unhealthy lifestyle behaviours.
Method:
Using a randomised controlled parallel trial design, participants were recruited in routine psychiatric care and allocated to CBT alone or MI-CBT. Means in feasibility measures and within-condition Hedges’ g effect sizes in treatment outcome measures were calculated. Authors were not blind to treatment allocation, while independent raters were blind.
Results:
Seventy-three patients were assessed for eligibility, and 49 were included. Participant perceptions of treatment credibility, expectancy for improvement, and working alliance were similar for both conditions. Overall, effect sizes were large across outcome measures for both conditions, including anxiety and depressive symptoms and functional impairment. However, therapists did not acquire sufficient competence in MI and the drop-out rate was high.
Conclusions:
MI-CBT proved feasible in some respects, but the present study did not support the progression to a randomised controlled trial designed to assess the effectiveness of MI-CBT. Additional pilot studies are needed.
Available evidence demonstrates that it is feasible to integrate Motivational Interviewing (MI) techniques with Enhanced Cognitive Behavioural Therapy (CBT) for the treatment of obesity and that this combined intervention has the potential to improve health-related outcomes of patients and to maintain behavioural changes over time. In addition, the use of Virtual Reality (VR) using embodiment techniques in the treatment of behavioural disorders has proved its preliminary effectiveness.
Objectives
1) to adapt the embodiment tool for treating obesity in a clinical setting, and 2) to compare its preliminary effectiveness to usual care.
Methods
A randomized control trial (SOCRATES project, funded by the European Union’s H2020 program under grant agreement No 951930) will be carried out with 66 participants with a Body Mass Index (BMI) >30, who will be split into two groups (control and intervention). The participants will be recruited from the external consultations of the Vall d’Hebron University Hospital. Readiness to change, BMI, dietetic habits and physical activity, self-perception of the body size, satisfaction with self-image and quality of life in relation to body image will be assessed before and after the intervention and at 4-week follow-up. Finally, variables related to the adoption of the VR tool in terms of perceived usability, user’s satisfaction and technology acceptance will be also evaluated.
Results
Not yet available
Conclusions
The study will provide an important advance in the treatment of obesity, first, by improving the effectiveness of available psychological treatments integrating embodiment, MI and CBT techniques, and second, reducing treatment duration and costs compared to conventional therapies.
One reason that motivational interviewing (MI) is thought to translate well to a variety of treatment domains is due to the focus on client ambivalence.
Aims:
Therefore, the current study aimed to explore the construct of ambivalence in the context of MI and cognitive behavioural therapy (CBT) for social anxiety disorder (SAD).
Method:
Participants were 147 individuals diagnosed with SAD who were randomised to receive either MI or supportive counselling prior to receiving group CBT for SAD.
Results:
The results suggested that MI was not related to decreases in general ambivalence or treatment ambivalence, although an indicator of treatment ambivalence was found to predict worse treatment outcome.
Conclusions:
The findings suggest that three sessions of MI prior to CBT may not decrease ambivalence in participants with SAD, which may underscore the potential importance of tackling ambivalence as it arises during CBT.
Family therapies for adolescents with attention deficit hyperactivity disorder (ADHD) face notorious engagement problems related to population-specific barriers. Supporting Teens’ Autonomy Daily (STAND) is an empirically-supported engagement-focused therapy for parents and teens with ADHD. In this chapter, we step into the lives of adolescents with ADHD and their parents, uncovering why therapeutic behavior change historically eluded this population. We describe the STAND model and discuss specific strategies that therapists can employ to enhance parent and teen engagement. Our approach draws from social psychology research on human motivation, change-oriented therapies such as motivational interviewing (MI), research on therapy homework and habit formation, behavioral principles and our own trial and error working with families. We share the results of three clinical trials that established STAND’s efficacy and discuss limitations and future directions for the evolving STAND model. We invite readers to collaborate with us in this process, creating their own brand of STAND to improve the lives of families.
Evidence for the idea that some individuals may experience an addictive-like response to certain foods has grown in the past decade. Food addiction parallels substance use disorders to suggest that highly processed foods (e.g., chocolate, French fries) may exhibit an addictive potential and trigger addictive-like responses in vulnerable individuals. An opposing conceptualization of addictive-like eating was recently developed, suggesting that the behavioral act of eating may be addictive rather than highly processed foods. However, the arguments for a behavioral eating addiction do not consider the central role of behaviors within substance use disorders and are not supported by preliminary research demonstrating that highly processed foods may directly contribute to the addictive-like eating phenotype. The primary goal of this chapter is to argue that a substance-based, food addiction framework is the most appropriate reflection of the current state of the literature and more closely parallels scientific understanding of addictive disorders. Specifically, this chapter will review theoretical debates between the food versus eating addiction perspectives, raise concerns about discrepancies between eating addiction and existing behavioral addictions, and review assessment tools for food and eating addiction. Finally, implications for stigma, intervention, and future research are discussed.
Approximately 23.5 million people in America need assistance for an alcohol, tobacco, or other drug use (ATOD) disorder, although many do not obtain the help that they need. This disorder is extremely difficult to resolve, as it can be hard to make the necessary lifestyle changes to accommodate sobriety. Sometimes, individuals may recover without formalized treatment, otherwise known as natural recovery. Other times, inpatient or outpatient treatment, or partial-hospitalization, is warranted. Even for individuals taking the proper steps and going to treatment, attrition rates are high, with consistent drop-out rates of 30 percent to 40 percent within three months of treatment initiation. Racial and gender disparities in both treatment participation and outcomes exist, indicating a need for tailoring of treatments and further research on breaking barriers to treatment entrance. Motivation is central in several recovery models proposed to explain stages of change in treatment. Treatment options include initial detoxification and pharmacological options (such as medication-assisted treatment using buprenorphine for opioid use disorder), cognitive-behavioral therapy, motivational interviewing, cue exposure, attentional retraining, twelve-step programs, and group/family therapy. Relapse rates are high, and oftentimes individuals move from one addiction to another. Harm reduction approaches may be beneficial to those that cannot fully quit an addiction, and relapse prevention is an important treatment component, as addiction is a life-long battle.
Skin cancer is a major public health issue with global rates of disease steadily on the rise. Intentional tanning behaviors, including sunbathing and indoor tanning, are high-risk practices strongly associated with an increased risk of skin cancer. Despite the known health risks, both indoor and outdoor tanning remain popular, particularly among young adult non-Hispanic white women. While all tanning increases the risk of skin cancer, in a subset of those who tan the behavior becomes frequent and excessive, with addiction-like properties. “Tanning addiction” is thus associated with the characteristics of other addictions such as craving for the behavior, a reinforcing effect, an inability to quit, and resulting adverse health consequences related to the behavior. Motivations driving tanning addiction may stem from both psychological factors such as appearance norms and from the physiologic effects of exposure to ultraviolet light on brain reward pathways influencing mood. In this chapter we present the concept of tanning as an addiction, reviewing its definition, measurement, and prevalence in the population, and outlining the empirical evidence for the behavioral and biological drivers of tanning addiction. The implications of this research, we suggest, warrants greater attention to this emerging addiction, and necessitates the development of effective prevention and treatment interventions in those at risk of addictive tanning.
This chapter provides an overview of the key areas of agreement and debate about workaholism, particularly its conceptualization, prevention, and treatment. The chapter integrates biomedical and health psychology perspectives with a view to challenging and advancing understanding on how to prevent people from developing a problematic relationship with work, and how best to support those experiencing the problem. The chapter begins by reviewing the conceptualization of workaholism, and then reviews the existing evidence concerning the main correlates and vulnerability factors. This discussion then leads to an exploration into alternative ways that workaholism can be theorized, in particular biopsychosocial models and critical theory of addiction. Building upon this combined theoretical perspective, the chapter ends by reviewing and speculating on different aspects of prevention and treatment according to the different stakeholders involved.